After a car crash, most people know to check for injuries and damage to our vehicles, but Consumer Reports says you should also check your child’s car seat. Emily Thomas is a car seat safety expert ...

CLEVELAND — A recent crash involving Consumer Reports' own car seat safety expert highlights an important question many parents face: when should you replace a child's car seat after an accident?

CHARLOTTE — After a car crash, most people know to check for injuries and damage to our vehicles, but Consumer Reports says you should also check your child’s car seat. Emily Thomas is a car seat ...

Patricia Arquette Doesn’t Know What Day It Is 90% of the Time Supreme Court Is Told Trump Tariffs Are Illegal $3 Trillion Tax A Massive New Study Says This Is What Happens to People Who Drink Black ...

A 2024 concept rendering of 11-15 W. Garrison St., along North New Street in Bethlehem, where 70 apartments are proposed. BETHLEHEM, Pa. – Bethlehem City Council voted to approve a zoning map change ...

Fans of McDonald’s famous McFlurry are taking to social media with one burning question: What happened to the flurrying of the McFlurry? Toppings like Oreos and M&M’s, once evenly blended into the ...

BERLIN (Reuters) -ZF Friedrichshafen will cut around a quarter of its workforce in its electrified powertrain technology unit by 2030 under a restructuring deal reached with its works council and ...

(Reuters) -Occidental Petroleum will sell its chemicals arm OxyChem to Warren Buffett's Berkshire Hathaway for $9.7 billion, the company said on Thursday, marking its biggest divestment yet to slash ...

New York (CNN) — Cracker Barrel has cut ties with the design firm that created its controversial new logo and redesigned restaurants. The restaurant chain started implementing the changes but quickly ...

Banks went into 2024 already juggling seismic change. Throughout the year and into 2025, executives were forced to prioritize trade-offs between growth, innovation-fueled transformation and safety in ...

Kyorin Pharmaceutical has strengthened its autoimmune portfolio by paying $10 million upfront for the Japanese rights to Hinge Bio’s preclinical lupus drug. The therapy, dubbed HB2198, targets both ...